Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX
Holding ALDX?
Track your performance easily

Aldeyra Therapeutics (ALDX) Ownership - Who Owns Aldeyra Therapeutics?

1,528 Followers

Aldeyra Therapeutics (ALDX) Ownership Overview

19.01%11.25%1.77%10.02%57.95%
19.01% Insiders
1.77% Other Institutional Investors
10.02% ETFs
57.95% Public Companies and
Individual Investors
The ownership structure of Aldeyra Therapeutics (ALDX) stock is a mix of institutional, retail, and individual investors. Approximately 23.04% of the company’s stock is owned by Institutional Investors, 19.01% is owned by Insiders, and 57.95% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 21, 2024
xxxxxxxxxxxxx
$10447
Aug 14, 2024
xxxxxxxxxxxxx
$75874
Apr 08, 2024
xxxxxxxxxxxxx
$833867
Apr 03, 2024
xxxxxxxxxxxxx
$1934505

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$30703066

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
9,275,851Insider15.58%50,924,422
9,275,851Institution15.58%50,924,422
2,879,990Institution4.84%15,811,145
2,493,755Institution4.19%13,690,715
2,041,473Institution3.43%11,207,687
1,471,298Insider2.47%8,077,426
680,004Institution1.14%3,733,222
647,683Institution1.09%3,555,780
552,478Institution0.93%3,033,104
530,393Institution0.89%2,911,858

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,493,755Institution4.19%13,690,715
680,004Institution1.14%3,733,222
552,478Institution0.93%3,033,104
530,393Institution0.89%2,911,858
495,144Institution0.83%2,718,341
310,125Institution0.52%1,702,586
265,151Institution0.45%1,455,679
239,261Institution0.40%1,313,543
206,748Institution0.35%1,135,047
166,232Institution0.28%912,614

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,758,714Institution2.95%9,479,468
1,378,270Institution2.31%7,566,702
697,567Institution1.17%3,759,886
635,905Institution1.07%3,491,118
420,555Institution0.71%2,308,847
228,767Institution0.38%1,233,054
144,982Institution0.24%781,453
113,049Institution0.19%620,639
107,102Institution0.18%591,203
85,356Institution0.14%468,604

FAQ

Who Owns Aldeyra Therapeutics (ALDX)?
According to the latest TipRanks data, approximately 1.77% of the company's stock is held by institutional investors, 19.01% is held by insiders, and 57.95% is held by retail investors.
    What percentage of Aldeyra Therapeutics (ALDX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.77% of Aldeyra Therapeutics (ALDX) stock is held by institutional investors.
      What percentage of Aldeyra Therapeutics (ALDX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 57.95% of Aldeyra Therapeutics (ALDX) stock is held by retail investors.
        Who owns the most shares of Aldeyra Therapeutics (ALDX)?
        Perceptive Advisors Llc owns the most shares of Aldeyra Therapeutics (ALDX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis